Murphy, S. P., Prescott, M. F., Camacho, A., Iyer, S. R., Maisel, A. S., Felker, G. M., … Januzzi, J. L. (2020). Atrial Natriuretic Peptide Mediates Reverse Cardiac Remodeling During Treatment with Sacubitril/Valsartan in Patients with Heart Failure with Reduced Ejection Fraction. In JOURNAL OF CARDIAC FAILURE (Vol. 26, pp. S15–S15).

Murphy, Sean P., Margaret F. Prescott, Alexander Camacho, Seethalakshmi R. Iyer, Alan S. Maisel, G Michael Felker, Javed Butler, et al. “Atrial Natriuretic Peptide Mediates Reverse Cardiac Remodeling During Treatment with Sacubitril/Valsartan in Patients with Heart Failure with Reduced Ejection Fraction.” In JOURNAL OF CARDIAC FAILURE, 26:S15–S15, 2020.

Murphy SP, Prescott MF, Camacho A, Iyer SR, Maisel AS, Felker GM, et al. Atrial Natriuretic Peptide Mediates Reverse Cardiac Remodeling During Treatment with Sacubitril/Valsartan in Patients with Heart Failure with Reduced Ejection Fraction. In: JOURNAL OF CARDIAC FAILURE. 2020. p. S15–S15.

Murphy, Sean P., et al. “Atrial Natriuretic Peptide Mediates Reverse Cardiac Remodeling During Treatment with Sacubitril/Valsartan in Patients with Heart Failure with Reduced Ejection Fraction.” JOURNAL OF CARDIAC FAILURE, vol. 26, no. 10, 2020, pp. S15–S15.

Murphy SP, Prescott MF, Camacho A, Iyer SR, Maisel AS, Felker GM, Butler J, Pina IL, Ibrahim NE, Abbas C, Burnett J, Solomon SD, Januzzi JL. Atrial Natriuretic Peptide Mediates Reverse Cardiac Remodeling During Treatment with Sacubitril/Valsartan in Patients with Heart Failure with Reduced Ejection Fraction. JOURNAL OF CARDIAC FAILURE. 2020. p. S15–S15.